An open label trial of venlafaxine in adults with attention deficit disorder

被引：0
|
作者：
Adler, LA
Resnick, S
Kunz, M
Devinsky, O
机构：
[1] NYU,SCH MED,HOSP JOINT DIS,PSYCHIAT SERV,NEW YORK,NY 10012
[2] NYU,SCH MED,HOSP JOINT DIS,NEUROL SERV,NEW YORK,NY 10012
[3] NEW YORK VAMC,NEW YORK,NY
来源：
BIOLOGICAL PSYCHIATRY | 1996年 / 39卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：421 / 421
页数：1
相关论文
共 50 条
  • [21] A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorder
    Joshi, Gagan
    DiSalvo, Maura
    Wozniak, Janet
    Ceranoglu, T. Atilla
    Yule, Amy
    Surman, Craig
    Fried, Ronna
    Galdo, Maribel
    Hoskova, Barbora
    Belser, Abigail
    Biederman, Joseph
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2020, 21 (04): : 274 - 290
  • [22] An open label trial of Venlafaxine in war veterans with Chronic Post Traumatic Stress Disorder
    Hopwood, M
    Morris, PLP
    Debenham, P
    Bonwick, R
    Parkin, I
    Ignatiadis, S
    Norman, T
    Burrows, GD
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2000, 34 : A31 - A31
  • [23] A Prospective Open-label Trial of Long-Acting Liquid Methylphenidate for the Treatment of Attention Deficit/Hyperactivity Disorder in Intellectually Capable Adults with Autism Spectrum Disorder
    Joshi, Gagan
    DiSalvo, Maura
    Ceranoglu, T. Atilla
    Wozniak, Janet
    Galdo, Maribel
    Hoskova, Barbora
    Dallenbach, Nina
    Castle, Rose
    Biederman, Joseph
    NEUROLOGY, 2019, 92 (15)
  • [24] Does OROS*-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder
    Fallu, Angelo
    Richard, Caroline
    Prinzo, Rosanna
    Binder, Carin
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (12) : 2557 - 2566
  • [25] An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder
    Wilens, TE
    Waxmonsky, J
    Scott, M
    Swezey, A
    Kwon, A
    Spencer, TJ
    Biederman, J
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) : 947 - 955
  • [26] AN OPEN TRIAL OF PARGYLINE IN THE TREATMENT OF ATTENTION DEFICIT DISORDER, RESIDUAL TYPE
    WENDER, PH
    WOOD, DR
    REIMHERR, FW
    WARD, M
    PSYCHIATRY RESEARCH, 1983, 9 (04) : 329 - 336
  • [27] AN OPEN TRIAL OF GUANFACINE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    HUNT, RD
    ARNSTEN, AFT
    ASBELL, MD
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1995, 34 (01): : 50 - 54
  • [28] A long-term, open-label trial of risperidone in children with bipolar disorder and comorbid attention-deficit/hyperactivity disorder
    Biederman, J
    Mick, E
    Wozniak, J
    Spencer, TJ
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) : 864 - 864
  • [29] Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial
    Golubchik, Pavel
    Sever, Jonathan
    Zalsman, Gil
    Weizman, Abraham
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 228 - 231
  • [30] A pilot clinical trial of oxcarbazepine in adults with attention deficit hyperactivity disorder
    Davids, E
    Specka, M
    Gastpar, M
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 235 - 236
12345